62 related articles for article (PubMed ID: 23011070)
1. Use of computer alerts to prevent the inappropriate use of metformin in an inpatient setting.
Rossi AP; Wellins CA; Savic M; Devlin JT
Qual Manag Health Care; 2012; 21(4):235-9. PubMed ID: 23011070
[TBL] [Abstract][Full Text] [Related]
2. Assessing the appropriate use of metformin in an inpatient setting and the effectiveness of two pharmacy-based measures to improve guideline adherence.
Scotton DW; Wierman H; Coughlan A; Walters M; Kuhn C
Qual Manag Health Care; 2009; 18(1):71-6. PubMed ID: 19148031
[TBL] [Abstract][Full Text] [Related]
3. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
[TBL] [Abstract][Full Text] [Related]
4. Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy.
Dichtwald S; Weinbroum AA; Sorkine P; Ekstein MP; Dahan E
Diabet Med; 2012 Feb; 29(2):245-50. PubMed ID: 21977945
[TBL] [Abstract][Full Text] [Related]
5. Development, implementation and outcome analysis of semi-automated alerts for metformin dose adjustment in hospitalized patients with renal impairment.
Niedrig D; Krattinger R; Jödicke A; Gött C; Bucklar G; Russmann S
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1204-1209. PubMed ID: 27418265
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients.
Kosmalski M; Drozdowska A; Sliwinska A; Drzewoski J
Adv Med Sci; 2012 Jun; 57(1):65-70. PubMed ID: 22543254
[TBL] [Abstract][Full Text] [Related]
7. Do risk factors for lactic acidosis influence dosing of metformin?
Millican S; Cottrell N; Green B
J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
9. Metformin-associated lactic acidosis in a low risk patient.
Ellis AK; Iliescu EA
Can J Clin Pharmacol; 2001; 8(2):104-6. PubMed ID: 11493939
[TBL] [Abstract][Full Text] [Related]
10. Metformin-associated lactic acidosis: case reports and literature review.
Chang CT; Chen YC; Fang JT; Huang CC
J Nephrol; 2002; 15(4):398-402. PubMed ID: 12243370
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
[TBL] [Abstract][Full Text] [Related]
13. Metformin use in decompensated heart failure.
Boyd A; Nawarskas J
Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
[TBL] [Abstract][Full Text] [Related]
14. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment.
Bruijstens LA; van Luin M; Buscher-Jungerhans PM; Bosch FH
Neth J Med; 2008 May; 66(5):185-90. PubMed ID: 18490795
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study.
Masoudi FA; Inzucchi SE; Wang Y; Havranek EP; Foody JM; Krumholz HM
Circulation; 2005 Feb; 111(5):583-90. PubMed ID: 15699279
[TBL] [Abstract][Full Text] [Related]
16. Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on food and drug administration contraindications.
Flory JH; Hennessy S
JAMA Intern Med; 2015 Mar; 175(3):458-9. PubMed ID: 25561419
[No Abstract] [Full Text] [Related]
17. Balancing risk and benefit with oral hypoglycemic drugs.
Hamnvik OP; McMahon GT
Mt Sinai J Med; 2009 Jun; 76(3):234-43. PubMed ID: 19421967
[TBL] [Abstract][Full Text] [Related]
18. Contraindications to metformin therapy among patients with type 2 diabetes mellitus.
Sweileh WM
Pharm World Sci; 2007 Dec; 29(6):587-92. PubMed ID: 17333496
[TBL] [Abstract][Full Text] [Related]
19. Metformin-associated lactic acidosis: a prognostic and therapeutic study.
Seidowsky A; Nseir S; Houdret N; Fourrier F
Crit Care Med; 2009 Jul; 37(7):2191-6. PubMed ID: 19487945
[TBL] [Abstract][Full Text] [Related]
20. The safety of metformin in heart failure.
Roberts F; Ryan GJ
Ann Pharmacother; 2007 Apr; 41(4):642-6. PubMed ID: 17374622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
